Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Hyperlipidaemia treatment and gut microbiology

View through CrossRef
Numerous studies have shown that hyperlipidaemia is closely related to the gut microbiota, and the study of microbiota in the treatment of hyperlipidaemia is undoubtedly a new target for the treatment and prevention of hyperlipidaemia. The efficacy of regulating the gut microecology and changing the structure of gut flora has been demonstrated by both western and traditional medication, biological therapy, and dietary exercise, so it is particularly important to study the relationship between gut microbiota and the treatment of hyperlipidaemia. In this review, we summarize the mechanism and relationship between the pathogenesis of hyperlipidaemia and gut microbiota, and the mechanism of hyperlipidaemia treatment by influencing the gut microbiota in various treatment modalities, which provides diversified therapeutic ideas and scientific basis for clinical treatment. It also triggers us to think about the relationship between gut microbiota and other diseases, and to explore the influence of gut microbiota is a goal that we still need to explore.
Title: Hyperlipidaemia treatment and gut microbiology
Description:
Numerous studies have shown that hyperlipidaemia is closely related to the gut microbiota, and the study of microbiota in the treatment of hyperlipidaemia is undoubtedly a new target for the treatment and prevention of hyperlipidaemia.
The efficacy of regulating the gut microecology and changing the structure of gut flora has been demonstrated by both western and traditional medication, biological therapy, and dietary exercise, so it is particularly important to study the relationship between gut microbiota and the treatment of hyperlipidaemia.
In this review, we summarize the mechanism and relationship between the pathogenesis of hyperlipidaemia and gut microbiota, and the mechanism of hyperlipidaemia treatment by influencing the gut microbiota in various treatment modalities, which provides diversified therapeutic ideas and scientific basis for clinical treatment.
It also triggers us to think about the relationship between gut microbiota and other diseases, and to explore the influence of gut microbiota is a goal that we still need to explore.

Related Results

EFFECTS OF ATORVASTATIN ON METHYLATION AND MRNA EXPRESSION OF BCL-2 IN HYPERLIPIDAEMIA WISTAR RATS
EFFECTS OF ATORVASTATIN ON METHYLATION AND MRNA EXPRESSION OF BCL-2 IN HYPERLIPIDAEMIA WISTAR RATS
Objectives To investigate effects of atorvastatin on methylation status of bcl-2 gene promoter and mRNA expression of bcl-2 in aortic tissue of hyperlipidaemia Wi...
Hyperlipidaemia and its risk factors in the Guangxi Bai Ku Yao and Han populations
Hyperlipidaemia and its risk factors in the Guangxi Bai Ku Yao and Han populations
AbstractObjectiveTo compare the differences in hyperlipidaemia prevalence and its risk factors between the Guangxi Bai Ku Yao and Han populations.DesignCross-sectional study of hyp...
Kismet/CHD7/CHD8 affects gut biomechanics, the gut microbiome, and gut-brain axis in Drosophila melanogaster
Kismet/CHD7/CHD8 affects gut biomechanics, the gut microbiome, and gut-brain axis in Drosophila melanogaster
Abstract The gut-brain axis may contribute to the pathophysiology of neurodevelopmental disorders, yet it is often unclear how risk genes associa...
Influence of Inflammation, Gut Microbiota, and Stress on Cognition and Oral Health Therapies
Influence of Inflammation, Gut Microbiota, and Stress on Cognition and Oral Health Therapies
Background: Prolonged or repeated psychological stress triggers dental and orthodontic diseases via inflammatory pathways and oxidative stress. This review aims to elucidate the ro...
Donepezil prevents cognitive impairment and gut epithelial disruption in doxorubicin‐treated rats
Donepezil prevents cognitive impairment and gut epithelial disruption in doxorubicin‐treated rats
AbstractBackgroundDonepezil (DPZ) is an acetylcholinesterase inhibitor used to improve cognitive function. We reported that it prevented doxorubicin (Dox)‐induced chemobrain. Gut e...

Back to Top